What is Regard?
Regard operates at the intersection of healthcare and artificial intelligence, providing a sophisticated platform designed to optimize clinical documentation and decision support. By leveraging real-time analysis of patient data, the company enables healthcare organizations to identify critical insights that might otherwise remain buried in unstructured records. This technology is engineered to reduce the administrative burden on clinicians, thereby allowing them to focus more effectively on patient care while simultaneously improving operational and financial outcomes for health systems.
In an era where data-driven decision-making is paramount, Regard distinguishes itself by augmenting existing electronic health record workflows with actionable intelligence. This approach not only enhances the quality of care but also addresses the systemic inefficiencies that plague modern medical environments, positioning the company as a vital partner for hospitals and clinics seeking to modernize their digital infrastructure.
How much funding has Regard raised?
Regard has raised a total of $106.3M across 2 funding rounds:
Series A
$15.3M
Series B
$91M
Series A (2022): $15.3M with participation from TenOneTen Ventures, Calibrate Ventures, Susa Ventures, and Foundry Group
Series B (2024): $91M led by Calibrate Ventures, Oak HC/FT, and Techstars
Key Investors in Regard
Oak HC/FT
Oak HC/FT is a premier venture growth-equity fund specializing in healthcare information and financial services technology, providing strategic counsel and board-level expertise to transformative companies.
Calibrate Ventures
Calibrate Ventures invests in early-revenue companies reshaping industries through advanced software, automation, and artificial intelligence, offering expert operational guidance to accelerate commercialization.
Techstars
Techstars is a global investment firm and accelerator that connects startups with a vast network of investors and corporations to foster thriving entrepreneurial communities.
What's next for Regard?
With the successful closure of this major strategic investment, Regard is poised to scale its operations and deepen its product capabilities. The company is expected to focus on expanding its market reach, potentially targeting larger health systems that require robust, AI-powered solutions to manage complex patient data environments. Furthermore, the influx of capital will likely support continued research and development, ensuring that their clinical intelligence platform remains at the forefront of medical innovation.
As Regard continues to navigate the complexities of the healthcare ecosystem, the focus will remain on demonstrating measurable ROI for its clients. By proving that its AI-driven insights lead to better patient outcomes and streamlined administrative processes, the company is well-positioned to solidify its status as a leader in the digital health transformation space.
